» Articles » PMID: 24307611

Squarticles As a Lipid Nanocarrier for Delivering Diphencyprone and Minoxidil to Hair Follicles and Human Dermal Papilla Cells

Overview
Journal AAPS J
Specialty Pharmacology
Date 2013 Dec 6
PMID 24307611
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Delivery of diphencyprone (DPCP) and minoxidil to hair follicles and related cells is important in the treatment of alopecia. Here we report the development of "squarticles," nanoparticles formed from sebum-derived lipids such as squalene and fatty esters, for use in achieving targeted drug delivery to the follicles. Two different nanosystems, nanostructured lipid carriers (NLC) and nanoemulsions (NE), were prepared. The physicochemical properties of squarticles, including size, zeta potential, drug encapsulation efficiency, and drug release, were examined. Squarticles were compared to a free control solution with respect to skin absorption, follicular accumulation, and dermal papilla cell targeting. The particle size of the NLC type was 177 nm; that of the NE type was 194 nm. Approximately 80% of DPCP and 60% of minoxidil were entrapped into squarticles. An improved drug deposition in the skin was observed in the in vitro absorption test. Compared to the free control, the squarticles reduced minoxidil penetration through the skin. This may indicate a minimized absorption into systemic circulation. Follicular uptake by squarticles was 2- and 7-fold higher for DPCP and minoxidil respectively compared to the free control. Fluorescence and confocal images of the skin confirmed a great accumulation of squarticles in the follicles and the deeper skin strata. Vascular endothelial growth factor expression in dermal papilla cells was significantly upregulated after the loading of minoxidil into the squarticles. In vitro papilla cell viability and in vivo skin irritancy tests in nude mice suggested a good tolerability of squarticles to skin. Squarticles provide a promising nanocarrier for topical delivery of DPCP and minoxidil.

Citing Articles

Targeting Acne: Development of Monensin-Loaded Nanostructured Lipid Carriers.

Abid F, Kim S, Savaliya B, Cesari L, Amirmostofian M, Abdella S Int J Nanomedicine. 2025; 20:2181-2204.

PMID: 39990290 PMC: 11847435. DOI: 10.2147/IJN.S497108.


Synergistic Fat-Reducing Effect of Deoxycholic Acid and Rhein in Lipid-Based Nanoparticles with Reduced Toxicity for Obesity Treatment.

Hsu C, Huang T, Lin Z, Chen C, Hwang E, Chen W Int J Nanomedicine. 2024; 19:12129-12151.

PMID: 39583324 PMC: 11585299. DOI: 10.2147/IJN.S494416.


Multi-dataset identification of innovative feature genes and molecular mechanisms in keratoconus.

Lyu N, Dai Y, Wu J, Fan Y, Lyu Z, Gu J J Cell Mol Med. 2024; 28(18):e70079.

PMID: 39300613 PMC: 11412914. DOI: 10.1111/jcmm.70079.


Advances and Prospects for Hydrogel-Forming Microneedles in Transdermal Drug Delivery.

Hou X, Li J, Hong Y, Ruan H, Long M, Feng N Biomedicines. 2023; 11(8).

PMID: 37626616 PMC: 10452559. DOI: 10.3390/biomedicines11082119.


Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata.

Guan Y, Yan A, Qiang W, Ruan R, Yang C, Ma K Int J Mol Sci. 2023; 24(9).

PMID: 37176141 PMC: 10179728. DOI: 10.3390/ijms24098427.


References
1.
Wosicka H, Cal K . Targeting to the hair follicles: current status and potential. J Dermatol Sci. 2010; 57(2):83-9. DOI: 10.1016/j.jdermsci.2009.12.005. View

2.
Borgia S, Regehly M, Sivaramakrishnan R, Mehnert W, Korting H, Danker K . Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release. 2005; 110(1):151-63. DOI: 10.1016/j.jconrel.2005.09.045. View

3.
Lee W, Shen S, Pai M, Yang H, Yuan C, Fang J . Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:YAG laser. J Control Release. 2010; 145(2):124-33. DOI: 10.1016/j.jconrel.2010.03.017. View

4.
Georgala S, Befon A, Maniatopoulou E, Georgala C . Topical use of minoxidil in children and systemic side effects. Dermatology. 2006; 214(1):101-2. DOI: 10.1159/000096924. View

5.
Otberg N, Patzelt A, Rasulev U, Hagemeister T, Linscheid M, Sinkgraven R . The role of hair follicles in the percutaneous absorption of caffeine. Br J Clin Pharmacol. 2007; 65(4):488-92. PMC: 2291387. DOI: 10.1111/j.1365-2125.2007.03065.x. View